Renal Cancer
A Phase 2, Open-label, Multicenter Study of IBI363 (PD1-IL2m) Alone or in Combination with Standard of Care Therapy in Participants in with Advanced Solid Malignancies (CIBI363A202)
- Details
ClinicalTrials.gov ID:
NCT06281678
Diagnosis Type:
NA
USOR Number:
- Address
,
P: